✦ LIBER ✦

Postoperative adjuvant chemotherapy in non-small cell lung cancer: Prognostic value of DNA ploidy and postrecurrent survival

✍ Scribed by Yukito Ichinose; Nobuyuki Hara; Mitsuo Ohta; Akira Motohiro; Tomoharu Kuda; Hiroshi Aso

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 490 KB
Volume: 46
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.2930460105

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification of postoperative adjuvant

Identification of postoperative adjuvant chemotherapy responders in non-small cell lung cancer by novel biomarker

✍ Takashi Hirano; Harubumi Kato; Masahiro Maeda; Yunbo Gong; Yanning Shou; Miho Na 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 491 KB

## Abstract Cisplatin‐based (CDDP‐based) adjuvant chemotherapy of non‐small cell lung cancer (NSCLC) was reported to yield 5–15% improvement in 5‐year survival compared to complete resection alone. The importance of information concerning preselection of good responders has become increasingly evid

Prognostic impact of local treatment aga

Prognostic impact of local treatment against postoperative oligometastases in non-small cell lung cancer

✍ Tokujiro Yano; Akira Haro; Tsukihisa Yoshida; Yosuke Morodomi; Kensaku Ito; Yasu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Quantitative analysis of p53 protein in

Quantitative analysis of p53 protein in non-small cell lung cancer and its prognostic value

✍ Michael A. Levesque; Mario D'Costa; Ernest H. Spratt; Mohammad M. Yaman; Elefthe 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 99 KB 👁 2 views

Accumulation of mutant p53 protein occurs frequently in human malignancies, including 40-60% of non-small cell lung carcinomas. The implications of such p53 over-expression, usually assessed by immunohistochemical techniques, for the prognosis of lung cancer patients remain undetermined. In this stu

Prognostic and therapeutic significance

Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer

✍ Hiroshi Isobe; Hiroshi Miyamoto; Toru Shimizu; Hitoshi Haneda; Masato Hashimoto; 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB 👁 2 views

Prognostic value of symptom burden for o

Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer

✍ Xin Shelley Wang; Qiuling Shi; Charles Lu; Ethan M. Basch; Valen E. Johnson; Tit 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 2 views

## Abstract ## BACKGROUND: Patient–reported outcomes have shown independent prognostic value for patients with nonsmall cell lung cancer (NSCLC). However, translating patient‐reported outcomes into useful prognostic information for individual patients has been problematic. ## METHODS: A total of

Lack of prognostic significance of serum

Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancer

✍ A.C. Hoffmann; J.T. Kaifi; D. Vallböhmer; E. Yekebas; P. Grimminger; J.M. Leers; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views